FDA inspection
Daniel R. Mishell, MD: FDA inspection ending Dec 14, 1999
FDA inspection 10579 · No Action Indicated (NAI) · Los Angeles, CA
Key facts
| Inspection ID | 10579 |
|---|---|
| Firm | Daniel R. Mishell, MD |
| FEI number | 2080597 |
| Address | Usc Keck School of Medicine, Dept Ob/Gyn, 2020 Zonal Ave Rm 505 |
| City | Los Angeles |
| State | CA |
| ZIP | 90089-0121 |
| Fiscal year | 2000 |
| Inspection end date | Dec 14, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data